No Data
No Data
Seres Therapeutics Names Thorell Finance Chief as Arkowitz Retires
Evelo Biosciences Shareholders Approve Dissolution Plan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
On December 1, 2023, Evelo Biosciences Was Notified By NASDAQ's Listing Qualifications That As A Result Of The Events Disclosed In Its Filing On November 21, The Staff Believes That The Company No Longer Has An Operating Business And Is Public Shell-8K
US Stocks Mixed; Dow Gains 50 Points
Regarding The Dissolution, Evelo Biosciences' Simba Gill Ceased Serving As The Company's President, CEO And President, And Marella Thorell Ceased Serving As The CFO, Secretary, Treasurer, Principal Financial Officer, And Principal Accounting Officer
No Data